Alkaline Phosphatase and Hyperphosphatasemia in Vitamin D Trial in Healthy Infants and Toddlers
The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e1082-e1091
DOI: 10.1210/clinem/dgad208 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.04.2023. Verfasst von Freja Pontán und 7 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland. Hauptthemen laut MEDLINE: Vitamin D, Alkaline Phosphatase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Lastentautien Tutkimussäätiö, Academy of Finland, Sigrid Jusélius Foundation.
Abstract (Originalsprache)
Context
Childhood hyperphosphatasemia is usually transient and may be associated with infections. It remains less well known how hyperphosphatasemia is related to growth and bone mineralization.
Objective
We explored alkaline phosphatase (ALP) concentrations and prevalence of hyperphosphatasemia, and their association with vitamin D, growth, infections, and bone parameters in healthy children.
Methods
The study was a secondary analysis of a vitamin D intervention trial. Participants received vitamin D3 10 or 30 µg daily from age 2 weeks to 2 years. Children with data on ALP at 12 and/or 24 months (n = 813, girls 51.9%) were included. Anthropometrics and bone parameters were measured at 12 and 24 months. Infections were recorded prospectively by the parents.
Results
Boys had higher ALP than girls at 12 months (median [IQR] 287 [241-345] U/L vs 266 [218-341] U/L; P = .02). At 24 months concentrations were lower than at 12 months (240 [202-284]; P < .001) but without sex difference. The prevalence of hyperphosphatasemia (ALP > 1000 U/L) at 12 months was 5.3% and at 24 months 0.6%. Body size, growth rate, and bone mineral content associated positively with ALP, while vitamin D intervention had no effect. Infants with hyperphosphatasemia were smaller than infants with ALP ≤ 1000 U/L. Hyperphosphatasemia was not associated with previous infections.
Conclusion
Approximately 5% of infants had hyperphosphatasemia at 12 months, but <1% at 24 months. ALP concentrations and hyperphosphatasemia were associated with sex, anthropometry, and bone mineralization. Infections did not contribute to hyperphosphatasemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland.
- Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
- Population Health Unit, Finnish Institute for Health and Welfare (THL), 00300 Helsinki, Finland.
- Clinical Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, 90014 Oulu, Finland.
- Institute of Genetics, Folkhälsan Research Center, 00290 Helsinki, Finland.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 77 Stockholm, Sweden.
ORCID-Profile: Helena Hauta-Alus, Jenni Rosendahl, Maria Enlund-Cerullo, Sture Andersson, Outi Mäkitie, Elisa Holmlund-Suila
Förderung
- Lastentautien Tutkimussäätiö
- Academy of Finland
- Sigrid Jusélius Foundation
- Folkhälsanin Tutkimussäätiö
- Novo Nordisk Foundation
- A Special Governmental Subsidy for Clinical Research
- Finska läkaresällskapet
- Stiftelsen Dorothea Olivia
Zitieren
APA
Pontán, F., Hauta-Alus, H., Valkama, S., Rosendahl, J., Enlund-Cerullo, M., Andersson, S., Mäkitie, O., & Holmlund-Suila, E. (2023). Alkaline Phosphatase and Hyperphosphatasemia in Vitamin D Trial in Healthy Infants and Toddlers. The Journal of Clinical Endocrinology & Metabolism, 108(10), e1082-e1091. https://doi.org/10.1210/clinem/dgad208
Vancouver
Pontán F, Hauta-Alus H, Valkama S, Rosendahl J, Enlund-Cerullo M, Andersson S, et al. Alkaline Phosphatase and Hyperphosphatasemia in Vitamin D Trial in Healthy Infants and Toddlers. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e1082-e1091. doi:10.1210/clinem/dgad208
BibTeX
@article{Pontn2023,
author = {Pontán, Freja and Hauta-Alus, Helena and Valkama, Saara and Rosendahl, Jenni and Enlund-Cerullo, Maria and Andersson, Sture and Mäkitie, Outi and Holmlund-Suila, Elisa},
title = {Alkaline Phosphatase and Hyperphosphatasemia in Vitamin D Trial in Healthy Infants and Toddlers},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {10},
pages = {e1082--e1091},
doi = {10.1210/clinem/dgad208}
}
EUVIMED